Advertisement
News
Advertisement

Amag Pharmaceuticals reports smaller losses

Thu, 11/01/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Amag Pharmaceuticals Inc. (Nasdaq: AMAG) reported a 39 percent spike in revenue and a 77 percent reduction in operating loss for the first nine months of the year as compared with the same time last year due to strong sales of its drug, Feraheme.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading